Literature DB >> 19673081

Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).

Isolete Pauli1, João Carlos Minozzo, Paulo Henrique da Silva, Olga Meiri Chaim, Silvio Sanches Veiga.   

Abstract

Bites by the brown spider (Loxosceles spp.) are an important health problem in South America, where three species predominate (Loxosceles laeta, Loxosceles gaucho, Loxosceles intermedia). Brown spider bites (loxoscelism) induce a block of cutaneous necrosis and, less commonly, may cause fatal systemic poisoning. A variety of controversial protocols are used to treat loxoscelism, while treatment with antivenin is the only venom specific treatment. Here we studied the action of the venom as well as the response to the antivenin for Loxosceles through an experimental study that simulates bites of L. intermedia (bites of this species are the most common in Brazil). Beneficial effects are known for antivenin applied quickly (within 4 h) after envenomation. Here we wished to examine the temporal development of the brown spider bite as well as the temporal patterns of the action of the antivenin to determine the time limits for beneficial use of the antivenin after envenomation. This information is important since most patients only appear for treatment several hours after being bitten. New Zealand rabbits were experimentally exposed to the venom from brown spiders by the injection of venom from L. intermedia (2x minimum necrotic dose), followed at regular time intervals by antivenin. The use of the loxoscelic antivenin--CPPI (4 mL per animal)--minimized the effects of envenomation when applied for up to 12 h after the injection of the venom, as evaluated by cutaneous (erythrema, edema, ecchymosis and necrosis) and systemic (blood cell and platelet counts, hematimetrics and fibrinogen dosage) criteria. Also, antivenin reduced the size of the necrotic area when applied up to 48 h after envenomation. Thus, therapy with loxoscelic antivenin, CPPI, may provide beneficial results by interfering with envenomation well after the bite occurred and therefore may become an important tool for medical treatment of brown spider bites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19673081     DOI: 10.1016/j.toxicon.2009.01.033

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  16 in total

1.  Brown Recluse Spider Bites in Patients With Neutropenia: A Single-institution Experience.

Authors:  Diego R Hijano; Daniel Otterson; Maysam R Homsi; Yin Su; Li Tang; Jeannette Kirby; Miguela A Caniza
Journal:  J Pediatr Hematol Oncol       Date:  2019-01       Impact factor: 1.289

Review 2.  Brown spider (Loxosceles genus) venom toxins: tools for biological purposes.

Authors:  Olga Meiri Chaim; Dilza Trevisan-Silva; Daniele Chaves-Moreira; Ana Carolina M Wille; Valéria Pereira Ferrer; Fernando Hitomi Matsubara; Oldemir Carlos Mangili; Rafael Bertoni da Silveira; Luiza Helena Gremski; Waldemiro Gremski; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2011-03-22       Impact factor: 4.546

Review 3.  Highlights in the knowledge of brown spider toxins.

Authors:  Daniele Chaves-Moreira; Andrea Senff-Ribeiro; Ana Carolina Martins Wille; Luiza Helena Gremski; Olga Meiri Chaim; Silvio Sanches Veiga
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-02-08

Review 4.  Biotechnological potential of Phospholipase D for Loxosceles antivenom development.

Authors:  Matías Fingermann; Adolfo Rafael de Roodt; Osvaldo Cascone; María Victoria Miranda
Journal:  Toxicon X       Date:  2020-04-18

5.  Effects of copaiba oil on dermonecrosis induced by Loxosceles intermedia venom.

Authors:  Mara Fernandes Ribeiro; Felipe Leite de Oliveira; Aline Moreira Souza; Thelma de Barros Machado; Priscilla Farinhas Cardoso; Andrea Patti; Angélica Silveira Nascimento; Cláudio Maurício Vieira de Souza; Sabrina Calil Elias
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-04-25

6.  Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies Against Loxosceles Spider Venom.

Authors:  Paula A L Calabria; Lhiri Hanna A L Shimokava-Falcao; Monica Colombini; Ana M Moura-da-Silva; Katia C Barbaro; Eliana L Faquim-Mauro; Geraldo S Magalhaes
Journal:  Toxins (Basel)       Date:  2019-02-12       Impact factor: 4.546

Review 7.  Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.

Authors:  Luiza Helena Gremski; Fernando Hitomi Matsubara; Nayanne Louise Costacurta Polli; Bruno Cesar Antunes; Pedro Henrique de Caires Schluga; Hanna Câmara da Justa; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Front Mol Biosci       Date:  2021-06-17

Review 8.  Poisonous Spiders: Bites, Symptoms, and Treatment; an Educational Review.

Authors:  Farzad Rahmani; Seyed Mahdi Banan Khojasteh; Hanieh Ebrahimi Bakhtavar; Farnaz Rahmani; Kavous Shahsavari Nia; Gholamreza Faridaalaee
Journal:  Emerg (Tehran)       Date:  2014

9.  Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon.

Authors:  Vanderson Souza Sampaio; André Alexandre Gomes; Iran Mendonça Silva; Jacqueline Sachett; Luiz Carlos Lima Ferreira; Sâmella Oliveira; Meritxell Sabidò; Hipócrates Chalkidis; Maria Graças Vale Barbosa Guerra; Jorge Luis Salinas; Fan Hui Wen; Marcus Vinícius Guimarães Lacerda; Wuelton Marcelo Monteiro
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

Review 10.  Venomous Arachnid Diagnostic Assays, Lessons from Past Attempts.

Authors:  Camila Dias-Lopes; Ana Luiza Paiva; Clara Guerra-Duarte; Franck Molina; Liza Felicori
Journal:  Toxins (Basel)       Date:  2018-09-10       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.